Evidence map›Paper›PMID 22606023›Full record

ArticleInternational journal of molecular sciences2012

2-decenoic acid ethyl ester, a compound that elicits neurotrophin-like intracellular signals, facilitating functional recovery from cerebral infarction in mice.

Yoshitaka Tanaka, Hidefumi Fukumitsu, Hitomi Soumiya, Shinichi Yoshimura, Toru Iwama, Shoei Furukawa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yoshitaka TanakaLaboratory of Molecular Biology, Gifu Pharmaceutical University, Daigaku-nishi, 1-25-4, Gifu 501-1190, Japan.
Hidefumi FukumitsuLaboratory of Molecular Biology, Gifu Pharmaceutical University, Daigaku-nishi, 1-25-4, Gifu 501-1190, Japan.
Hitomi SoumiyaLaboratory of Molecular Biology, Gifu Pharmaceutical University, Daigaku-nishi, 1-25-4, Gifu 501-1190, Japan.
Shinichi YoshimuraDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu 501-1194, Japan.
Toru IwamaDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu 501-1194, Japan.
Shoei FurukawaLaboratory of Molecular Biology, Gifu Pharmaceutical University, Daigaku-nishi, 1-25-4, Gifu 501-1190, Japan.
Gifu Pharmaceutical University · JPGifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our previous study, we found that trans-2-decenoic acid ethyl ester (DAEE), a derivative of a medium-chain fatty acid, elicits neurotrophin-like signals including the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in cultured mouse cortical neurons. Here, we examined the efficacy of intraperitoneal administration of DAEE on the treatment of a mouse model of the cerebral infarction caused by unilateral permanent middle cerebral artery occlusion (PMCAO). DAEE-treatment (100 μg/kg body weight injected at 0.5, 24, 48, 72 h after PMCAO) significantly restored the mice from PMCAO-induced neurological deficits including motor paralysis when evaluated 48, 72, and 96 h after the PMCAO. Furthermore, DAEE facilitated the phosphorylation of ERK1/2 on the infarction side of the brain when analyzed by Western immunoblot analysis, and it enhanced the number of phosphorylated ERK1/2-positive cells in the border areas between the infarction and non-infarction regions of the cerebral cortex, as estimated immunohistochemically. As the infarct volume remained unchanged after DAEE-treatment, it is more likely that DAEE improved the neurological condition through enhanced neuronal functions of the remaining neurons in the damaged areas rather than by maintaining neuronal survival. These results suggest that DAEE has a neuro-protective effect on cerebral infarction.

Indexed as

AnimalsBlood-Brain BarrierBrain-Derived Neurotrophic FactorCerebral CortexCerebral InfarctionDisease Models, AnimalExtracellular Signal-Regulated MAP KinasesFatty Acids, MonounsaturatedInfarction, Middle Cerebral ArteryMaleMiceNerve Growth FactorsNeuroprotective AgentsOxidative StressParalysisPhosphorylation2-decenoic acidBrain-Derived Neurotrophic FactorExtracellular Signal-Regulated MAP KinasesFatty Acids, MonounsaturatedNerve Growth FactorsNeuroprotective Agents2-decenoic acid ethyl estercerebral infarctionextracellular signal-regulated kinases 1 and 2neurotrophin

Identifiers

PMID22606023
PMCPMC3344259
OpenAlexW1981603026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.